Polypeptide growth factors are positive and negative regulators of prostatic growth and function, and many positive regulators of growth in the prostate have been extensively studied. However, very few inhibitors of prostate cell proliferation have been identified. We have isolated a unique 18-kDa s
Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis
✍ Scribed by Kushlani Gunawardena; Darrell K. Murray; A. Wayne Meikle
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 456 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The purpose of these experiments was to assess the synergistic activity of silibinin with chemotherapy agents in clinical use against prostate cancer. Silybin‐phytosome, a commercially available formulation containing silibinin, has recently been studied in a phase I clinical trial. The
microRNAs (miRNAs) play vital roles in several biological processes, including apoptosis, by negatively regulating the expression of target genes. The molecular mechanisms of the key survival signal, Akt family, have been widely explored. However, it remains to be ascertained whether Akt1, the predo
## Abstract Microarray analyses of human MDA‐MB‐435 breast cancer cells treated with vitamin E analog 2,5,7,8‐tetramethyl‐2R‐(4R,8R,12‐trimethyltridecyl) chroman‐6‐yloxy acetic acid (α‐TEA) showed over 400 genes to be modulated. Thirty‐four genes deemed of interest based on potential involvement in
## Abstract cFLIP inhibits caspase 8 recruitment and processing at the death‐inducing signaling complex (DISC), which is known to inhibits apoptosis mediated by death receptors such as Fas and death receptor 5 (DR5) as well as apoptosis mediated by anticancer therapeutic drugs. We observed that oxa
The above article, published online on April 10 2008 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor in Chief and Wiley Periodicals, Ltd. The retraction has been agreed due to data duplication, both from previous papers from the same group